VolitionRx Limited Operating Leases, Future Minimum Payments, Due in Rolling Year Two and Three
VolitionRx Limited (VNRX) had Operating Leases, Future Minimum Payments, Due in Rolling Year Two and Three of $13.98 thousand as of 2017-12-31, per its 10-K filed 2018-03-01.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwoAndThree · last filed 2018-03-01
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Rolling Year Two and Three $13.98K.
| Period end | Operating Leases, Future Minimum Payments, Due in Rolling Year Two and Three |
|---|---|
| 2017-12-31 | $13.98K 10-K · filed 2018-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |